|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.60 SEK | -5.49% |
|
-11.85% | -17.70% |
| 07-20 | SynAct Pharma Draws SEK50 Million from New Financing Facility | MT |
| 07-20 | Synact Pharma secures access to financing of up to €9.0m | FW |
| Market Cap | 990M 102M 89.55M 82.78M 76.13M 144M 9.85B 146M 388M 4.82B 384M 375M 16.61B | P/E 2026 * |
-12.5x | P/E 2027 * | -24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 972M 100M 87.97M 81.31M 74.79M 141M 9.68B 143M 381M 4.74B 377M 369M 16.32B | EV / Sales 2026 * |
7.01x | EV / Sales 2027 * | 48x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | -5.49% | ||
| 1 week | -11.85% | ||
| Current month | -11.64% | ||
| 1 month | +59.52% | ||
| 3 months | +8.39% | ||
| 6 months | -18.42% | ||
| Current year | -17.70% |
| 1 week | 18.5 |  | 20.95 |
| 1 month | 12.36 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 31/12/2013 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 28/02/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 14/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Sten Scheibye
BRD | Director/Board Member | 74 | 19/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 19/03/2024 |
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 19/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/03/26 | Buy | Chairman | 2,750 | 0.0052% | ||
| 09/03/26 | Buy | Executive/Senior Manager | 1,500 | 0.0028% | ||
| 09/03/26 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.49% | -11.85% | -14.68% | -81.23% | 102M | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,023B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 599B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 448B | |
| -0.75% | +0.30% | +28.32% | +21.15% | 326B | |
| -1.52% | -1.19% | +33.38% | +35.35% | 278B | |
| -1.70% | -1.82% | +20.26% | +15.74% | 258B | |
| -0.58% | +1.11% | -20.89% | -40.59% | 222B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 197B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 165B | |
| Average | -1.23% | -1.53% | +22.75% | +34.64% | 351.52B | |
| Weighted average by Cap. | -0.88% | -1.18% | +35.16% | +70.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.32M 12.55M 11.6M 10.67M 20.14M 1.38B 20.46M 54.39M 676M 53.78M 52.61M 2.33B | 21.15M 2.18M 1.91M 1.77M 1.63M 3.07M 211M 3.12M 8.29M 103M 8.2M 8.02M 355M |
| Net income | 52.18M 5.39M 4.72M 4.36M 4.01M 7.57M 519M 7.69M 20.45M 254M 20.22M 19.78M 875M | -26.04M -2.69M -2.36M -2.18M -2M -3.78M -259M -3.84M -10.21M -127M -10.1M -9.87M -437M |
| Net Debt | -17.48M -1.8M -1.58M -1.46M -1.34M -2.54M -174M -2.58M -6.85M -85.13M -6.78M -6.63M -293M | 24.86M 2.57M 2.25M 2.08M 1.91M 3.61M 247M 3.67M 9.75M 121M 9.64M 9.43M 417M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | SEK 18.60 | -5.49% | 368,898 |
| 17/07/26 | SEK 19.68 | +0.41% | 130,856 |
| 16/07/26 | SEK 19.60 | +0.41% | 105,576 |
| 15/07/26 | SEK 19.52 | -2.89% | 127,568 |
| 14/07/26 | SEK 20.10 | -4.74% | 134,541 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
